Since then, several others have followed, including dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), semaglutide (Ozempic, Wegovy), and the latest FDA-approved medication, tirzepatide (Mounjaro, Zepbound)
However, as discussed in the accompanying paper [6], the single screening round of DMSA had an unexpectedly dramatic effect on improving abnormal glutathione and platelet levels, and that effect lasted through the end of phase 2, so that phase 2 turned out in practice not to be a placebo-controlled investigation
Providers can consult with Novo Nordisk, the FDA-approved supplier of semaglutide, for more information on the drug and its proper usage
Novo Nordisks data shows that patients with Type 2 diabetes are seeing their hemoglobin A1C levels drop to under 7